Effect of biologic drugs on renal function in psoriasis patients with chronic kidney disease - 14/04/20
Doi : 10.1016/j.jaad.2019.12.043
Jalal Maghfour, MS, Erika Elliott, BA, Frances Gill, BS, MPH, Brittany Stumpf, MD, Andrea Murina, MD ⁎ 
Tulane University School of Medicine, Department of Dermatology, New Orleans, Louisiana
∗Correspondence to: Andrea Murina, MD, Tulane University School of Medicine, Department of Dermatology, 1430 Tulane Avenue #8036, New Orleans, LA 70112Tulane University School of MedicineDepartment of Dermatology1430 Tulane Avenue #8036New OrleansLA70112
| Funding sources: None. |
|
| Conflicts of interest: Dr Murina is a speaker for AbbVie, Celgene, Eli Lilly and Company, Janssen, and Novartis. She has served on advisory boards for Ortho Dermatologics and Janssen. |
|
| IRB approval status: Reviewed and approved by Tulane IRB (2019-183). |
|
| Reprints not available from the authors. |
© 2019
American Academy of Dermatology, Inc. Tous droits réservés.
Vol 82 - N° 5
P. 1249-1251 - mai 2020 Retour au numéro
Article précédent
- Conjunctivitis in patients with atopic dermatitis treated with dupilumab is associated with higher baseline serum levels of immunoglobulin E and thymus and activation-regulated chemokine but not clinical severity in a real-world setting
- Hideaki Uchida, Masahiro Kamata, Mayumi Nagata, Saki Fukaya, Kotaro Hayashi, Atsuko Fukuyasu, Takamitsu Tanaka, Takeko Ishikawa, Takamitsu Ohnishi, Yayoi Tada
- Dupilumab for the treatment of dyshidrotic eczema in 15 consecutive patients
- Reid A. Waldman, Madeline E. DeWane, Brett Sloan, Jane M. Grant-Kels, Jun Lu
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?